TY  - GEN
T1  - Key Heterocyclic Cores for Smart Anticancer Drug-Design Part II.
A2  - Singh, Rajesh Kumar
LA  - English
PP  - Sharjah
PB  - Bentham Science Publishers
YR  - 2022
UL  - https://ebooks.jgu.edu.in/Record/ebsco_acadsubs_on1348484310
AB  - This book provides an update on heterocyclic compounds that serve as key components of anti-cancer agents administered in pre-clinical settings. Many of the compounds highlighted in the book are being actively investigated for the bioactive properties against a range of cancer cell lines. There is potential for heterocyclic compounds to design agents that can target specific molecules to treat different types of cancers. Chapters are contributed by experts in.
OP  - 231
NO  - Description based upon print version of record.
CN  - RC271.C5
SN  - 9815040049
SN  - 9789815040043
SN  - 9789815040050
KW  - Cancer : Chemotherapy.
KW  - Cancer : Treatment.
KW  - Drugs : Design.
KW  - Cyclic compounds.
KW  - Drug Design
KW  - Cancer : Traitement.
KW  - Cancer : Chimiothérapie.
KW  - Médicaments : Conception.
KW  - Composés cycliques.
ER  -